Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Plasmodium Falciparum | Research

Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda

Authors: Constance Agwang, Joseph Erume, Brenda Okech, Joseph Olobo, Thomas G. Egwang

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

The development of malaria vaccines is constrained by genetic polymorphisms exhibited by Plasmodium falciparum antigens. The project the age-dependent distribution of alleles or haplotypes of three P. falciparum malaria vaccine candidates, Circumsporozoite Protein (csp), Erythrocyte Binding Antigen 175 (eba-175) and Serine Repeat Antigen 5 (sera5) in a region of intense malaria transmission in Uganda.

Methods

A cross-sectional study was carried out between August and November 2009 in which 250 study participants were selected from a population of 600. Finger prick blood samples were collected after informed consent from participants below 5 years, 5–10 years, and above 10 years of age. Blood was used for microscopy, RDT and dried blood spots. Plasmodium falciparum DNA was extracted by chelex method. Alleles of sera5 and eba-175 were determined by polymerase chain reaction (PCR) amplification followed by resolution of products by agarose gel electrophoresis. Allele calling was done using gel photographs from ethiduim bromide stained gels. Haplotypes of csp were identified by sequencing 63 PCR products using the P. falciparum 7G8 laboratory strain sequence as a reference. The data were analysed using SPSS 16, EQX for windows and Chi-square test was used to calculate associations (P-values), Excel was used to generate graphs. The BioEdit and NCBI blast software programs were used to analyse the sequences from which csp haplotypes map was constructed.

Results

Eba-175 FCR3 (48/178) and CAMP (16/178) alleles were observed, the FCR3 (24/67) allele being predominant among children aged below 5 years old while the CAMP (12/67) allele was predominant among older participants. Sera5 alleles ORI (6/204) and ORII (103/204) were observed in the population, ORII was more prevalent and was significantly associated with age (P values < 0.0001), parasite density (P-value < 0.0001) and clinical outcomes (P value = 0.018). There was marked csp diversity in the Th2/Th3 region. Out of 63 sequences, 16 conformed to the reference strain and one (1/16) was similar to a West African haplotype and the majority (14/16) of the haplotypes were unique to this study region. There was an age-dependent distribution of csp haplotypes with more haplotypes being harbored by children < 5-year of age, (10/16) compared to adults (2/16). Interestingly, the csp haplotype corresponding to 3D7 whose prototypical sequence is identical to the sequence of the leading malaria vaccine candidate RTS, S was not observed.

Conclusion

This data suggest that the eba-175 FCR3 allele, sera5 ORII allele, and csp haplotypes are targets of host immunity and under immune selection pressure in Apac District. These molecules could provide alternative malaria vaccine candidates as sub-unit vaccines.
Literature
1.
go back to reference World Health Organization. World malaria report. Geneva: World Health Organization; 2019. World Health Organization. World malaria report. Geneva: World Health Organization; 2019.
2.
go back to reference Butler D, Maurice J, O’Brien C. Briefing malaria: time to put malaria control on the global agenda. Nature. 1997;386:535–6.CrossRef Butler D, Maurice J, O’Brien C. Briefing malaria: time to put malaria control on the global agenda. Nature. 1997;386:535–6.CrossRef
3.
go back to reference CDC. Malaria control in Uganda. In: Towards the Abuja targets. Atlanta. 2004. CDC. Malaria control in Uganda. In: Towards the Abuja targets. Atlanta. 2004.
4.
go back to reference Greenwood B. Malaria vaccines: evaluation and implementation. Acta Trop. 2005;95:298–304.CrossRef Greenwood B. Malaria vaccines: evaluation and implementation. Acta Trop. 2005;95:298–304.CrossRef
5.
go back to reference Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H. Chloroquine resistance of Plasmodium falciparum: a biological advantage? Trans R Soc Trop Med Hyg. 1995;89:90–1.CrossRef Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H. Chloroquine resistance of Plasmodium falciparum: a biological advantage? Trans R Soc Trop Med Hyg. 1995;89:90–1.CrossRef
6.
go back to reference Girard MP, Reed ZH, Friede M, Kieny MP. A review of human vaccine research and development: malaria. Vaccine. 2007;25:1567–80.CrossRef Girard MP, Reed ZH, Friede M, Kieny MP. A review of human vaccine research and development: malaria. Vaccine. 2007;25:1567–80.CrossRef
7.
go back to reference Li J, Mitamura T, Fox BA, Bzik DJ, Horii T. Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol Int. 2002;51:343–52.CrossRef Li J, Mitamura T, Fox BA, Bzik DJ, Horii T. Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol Int. 2002;51:343–52.CrossRef
8.
go back to reference Barnwell JW, Galinski MR. Invasion of vertebrate cells erythrocytes. Berlin: ScienceOpen; 1998. p. 93–120. Barnwell JW, Galinski MR. Invasion of vertebrate cells erythrocytes. Berlin: ScienceOpen; 1998. p. 93–120.
9.
go back to reference Kain KC, Lanar DE. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol. 1991;29:1171–4.CrossRef Kain KC, Lanar DE. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol. 1991;29:1171–4.CrossRef
10.
go back to reference Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–8.CrossRef Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–8.CrossRef
11.
go back to reference Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG. Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1 19) and predominance of the MAD20 allelic type of MSP1 in Uganda. East Afr Med J. 2000;77:189–93.PubMed Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG. Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1 19) and predominance of the MAD20 allelic type of MSP1 in Uganda. East Afr Med J. 2000;77:189–93.PubMed
12.
go back to reference Okello PE, Van Bortel W, Byaruhanga AB, Correwyn A, Roelants P, Talisuna A, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg. 2006;75:219–25.CrossRef Okello PE, Van Bortel W, Byaruhanga AB, Correwyn A, Roelants P, Talisuna A, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg. 2006;75:219–25.CrossRef
13.
go back to reference Egwang T, Apio B, Riley E, Okello D. Plasmodium falciparum malariometric indices in Apac district, northern Uganda. East Afr Med J. 2000;77:413–6.PubMed Egwang T, Apio B, Riley E, Okello D. Plasmodium falciparum malariometric indices in Apac district, northern Uganda. East Afr Med J. 2000;77:413–6.PubMed
14.
go back to reference Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP. The dynamics of naturally acquired immunity to Plasmodium falciparum infection. PLoS Comput Biol. 2012;8:e1002729.CrossRef Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP. The dynamics of naturally acquired immunity to Plasmodium falciparum infection. PLoS Comput Biol. 2012;8:e1002729.CrossRef
15.
go back to reference Mmbando BP, Lusingu JP, Vestergaard LS, Lemnge MM, Theander TG, Scheike TH. Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania. BMC Med Res Methodol. 2009;9:75.CrossRef Mmbando BP, Lusingu JP, Vestergaard LS, Lemnge MM, Theander TG, Scheike TH. Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania. BMC Med Res Methodol. 2009;9:75.CrossRef
16.
go back to reference Enosse S, Dobano C, Quelhas D, Aponte JJ, Lievens M, Leach A, et al. RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trial. 2006;1:e5.CrossRef Enosse S, Dobano C, Quelhas D, Aponte JJ, Lievens M, Leach A, et al. RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trial. 2006;1:e5.CrossRef
17.
go back to reference Pratt-Riccio LR, Sallenave-Sales S, Oliveira-Ferreira J, da Silva BT, Guimaraes ML, Santos F, et al. Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon. Malar J. 2008;7:144.CrossRef Pratt-Riccio LR, Sallenave-Sales S, Oliveira-Ferreira J, da Silva BT, Guimaraes ML, Santos F, et al. Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon. Malar J. 2008;7:144.CrossRef
18.
go back to reference Touré FS, Mavoungou E, Ndong JM, Tsipamba P, Deloron P. Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction. Trop Med Int Health. 2001;6:767–9.CrossRef Touré FS, Mavoungou E, Ndong JM, Tsipamba P, Deloron P. Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction. Trop Med Int Health. 2001;6:767–9.CrossRef
19.
go back to reference Jalloh A, Jalloh M, Matsuoka H. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution? Malar J. 2009;8:120.CrossRef Jalloh A, Jalloh M, Matsuoka H. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution? Malar J. 2009;8:120.CrossRef
20.
go back to reference Dittrich S, Schwöbel B, Jordan S, Vanisaveth V, Rattanaxay P, Christophel EM, et al. Distribution of the two forms of Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene in Lao PDR. Malar J. 2003;2:23.CrossRef Dittrich S, Schwöbel B, Jordan S, Vanisaveth V, Rattanaxay P, Christophel EM, et al. Distribution of the two forms of Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene in Lao PDR. Malar J. 2003;2:23.CrossRef
21.
go back to reference Hamid MM, Elamin AF, Albsheer MM, Abdalla AA, Abdelmohaymin AA, Mahgoub NS, et al. Multiplicity of infection and genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria in Gezira State, Sudan. Parasit Vectors. 2016;9:362.CrossRef Hamid MM, Elamin AF, Albsheer MM, Abdalla AA, Abdelmohaymin AA, Mahgoub NS, et al. Multiplicity of infection and genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria in Gezira State, Sudan. Parasit Vectors. 2016;9:362.CrossRef
22.
go back to reference Soulama I, Bigoga JD, Ndiaye M, Bougouma EC, Quagraine J, Casimiro PN, et al. Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen-1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from western and central Africa. Am J Trop Med Hyg. 2011;84:276–84.CrossRef Soulama I, Bigoga JD, Ndiaye M, Bougouma EC, Quagraine J, Casimiro PN, et al. Genetic diversity of polymorphic vaccine candidate antigens (apical membrane antigen-1, merozoite surface protein-3, and erythrocyte binding antigen-175) in Plasmodium falciparum isolates from western and central Africa. Am J Trop Med Hyg. 2011;84:276–84.CrossRef
23.
go back to reference Delplace P, Dubremetz JF, Fortier B, Vernes A. A 50 kilodalton exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum. Mol Biochem Parasitol. 1985;17:239–51.CrossRef Delplace P, Dubremetz JF, Fortier B, Vernes A. A 50 kilodalton exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum. Mol Biochem Parasitol. 1985;17:239–51.CrossRef
24.
go back to reference Debrabant A, Delplace P. Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1989;33:151–8.CrossRef Debrabant A, Delplace P. Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1989;33:151–8.CrossRef
25.
go back to reference Safitri I, Jalloh A, Tantular IS, Pusarawati S, Win TT, Liu Q, et al. Sequence diversity in the amino-terminal region of the malaria-vaccine candidate serine repeat antigen in natural Plasmodium falciparum populations. Parasitol Int. 2003;52:117–31.CrossRef Safitri I, Jalloh A, Tantular IS, Pusarawati S, Win TT, Liu Q, et al. Sequence diversity in the amino-terminal region of the malaria-vaccine candidate serine repeat antigen in natural Plasmodium falciparum populations. Parasitol Int. 2003;52:117–31.CrossRef
26.
go back to reference Sim B, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science. 1994;264:1941–4.CrossRef Sim B, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science. 1994;264:1941–4.CrossRef
27.
go back to reference Sim B, Orlandi PA, Haynes JD, Klotz FW, Carter JM, Camus D, et al. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol. 1990;111:1877–84.CrossRef Sim B, Orlandi PA, Haynes JD, Klotz FW, Carter JM, Camus D, et al. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol. 1990;111:1877–84.CrossRef
28.
go back to reference Liang H, Sim B. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol Biochem Parasitol. 1997;2:241–5.CrossRef Liang H, Sim B. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol Biochem Parasitol. 1997;2:241–5.CrossRef
29.
go back to reference Binks RH, Baum J, Oduola AM, Arnot DE, Babiker HA, Kremsner PG, et al. Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene. Mol Biochem Parasitol. 2001;114:63–70.CrossRef Binks RH, Baum J, Oduola AM, Arnot DE, Babiker HA, Kremsner PG, et al. Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene. Mol Biochem Parasitol. 2001;114:63–70.CrossRef
30.
go back to reference Cramer JP, Mockenhaupt FP, Möhl I, Dittrich S, Dietz E, Otchwemah RN, et al. Allelic dimorphism of the erythocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: significant association of the C-segment with fatal outcome in Ghanaian children. Malar J. 2004;3:11.CrossRef Cramer JP, Mockenhaupt FP, Möhl I, Dittrich S, Dietz E, Otchwemah RN, et al. Allelic dimorphism of the erythocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: significant association of the C-segment with fatal outcome in Ghanaian children. Malar J. 2004;3:11.CrossRef
31.
go back to reference Tanabe K, Sakihama N, Kaneko A. Stable SNPs in malaria antigen genes in isolated populations. Science. 2004;303:493–4.CrossRef Tanabe K, Sakihama N, Kaneko A. Stable SNPs in malaria antigen genes in isolated populations. Science. 2004;303:493–4.CrossRef
32.
go back to reference Kumkhaek C, Phra-Ek K, Renia L, Singhasivanon P, Looareesuwan S, Hirunpetcharat C, et al. Are extensive T cell epitope polymorphisms in the circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? J Immunol. 2005;175:3935–9.CrossRef Kumkhaek C, Phra-Ek K, Renia L, Singhasivanon P, Looareesuwan S, Hirunpetcharat C, et al. Are extensive T cell epitope polymorphisms in the circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? J Immunol. 2005;175:3935–9.CrossRef
Metadata
Title
Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda
Authors
Constance Agwang
Joseph Erume
Brenda Okech
Joseph Olobo
Thomas G. Egwang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03432-0

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.